UBS ASSET MANAGEMENT AMERICAS INC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 122 filers reported holding TRANSMEDICS GROUP INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$2,580,588
-17.2%
47,134
+14.5%
0.00%
-50.0%
Q2 2023$3,117,7290.0%41,1690.0%0.00%0.0%
Q1 2023$3,117,729
+28.8%
41,169
+5.0%
0.00%
+100.0%
Q4 2022$2,420,781
-99.8%
39,222
+27.2%
0.00%0.0%
Q3 2022$1,287,137,000
+25.0%
30,837
-5.8%
0.00%0.0%
Q2 2022$1,029,704,000
+16.7%
32,7410.0%0.00%
Q1 2022$882,043,000
+54.3%
32,741
+9.8%
0.00%
Q4 2021$571,543,000
-42.1%
29,8300.0%0.00%
Q3 2021$987,074,000
+25.1%
29,830
+25.4%
0.00%
Q2 2021$789,054,00023,7810.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders